Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Cancer Research
|
February 21, 2012
CDK8 maintains tumor dedifferentiation and embryonic stem cell pluripotency
Adam S Adler, Mark L McCleland, Tom Truong, et al.
The Journal of Clinical Investigation
|
January 12, 2016
CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer
Mark L McCleland, Kathryn Mesh, Edward Lorenzana, et al.
Current Biology : CB
|
January 24, 2004
The vertebrate Ndc80 complex contains Spc24 and Spc25 homologs, which are required to establish and maintain kinetochore-microtubule attachment
Mark L McCleland, Marko J Kallio, Gregory A Barrett-Wilt, et al.
The Journal of Pathology
|
August 4, 2015
Cdk8 deletion in the Apc(Min) murine tumour model represses EZH2 activity and accelerates tumourigenesis
Mark L McCleland, Tim M Soukup, Scot D Liu, et al.
Blood
|
April 4, 2002
Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy
Jane D Mount, Roland W Herzog, D Michael Tillson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 11, 2012
Lactate dehydrogenase B is required for the growth of KRAS-dependent lung adenocarcinomas
Mark L McCleland, Adam S Adler, Laura Deming, et al.
ACS Medicinal Chemistry Letters
|
March 18, 2016
Development of a Potent, Specific CDK8 Kinase Inhibitor Which Phenocopies CDK8/19 Knockout Cells
Michael F T Koehler, Philippe Bergeron, Elizabeth M Blackwood, et al.
Cancer Research
|
November 10, 2012
An integrated genomic screen identifies LDHB as an essential gene for triple-negative breast cancer
Mark L McCleland, Adam S Adler, Yonglei Shang, et al.
ACS Medicinal Chemistry Letters
|
June 22, 2016
Design and Development of a Series of Potent and Selective Type II Inhibitors of CDK8
Philippe Bergeron, Michael F T Koehler, Elizabeth M Blackwood, et al.
Genes & Development
|
May 3, 2014
An integrative analysis of colon cancer identifies an essential function for PRPF6 in tumor growth
Adam S Adler, Mark L McCleland, Sharon Yee, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Cancer Research
|
February 21, 2012
CDK8 maintains tumor dedifferentiation and embryonic stem cell pluripotency
Adam S Adler, Mark L McCleland, Tom Truong, et al.
The Journal of Clinical Investigation
|
January 12, 2016
CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer
Mark L McCleland, Kathryn Mesh, Edward Lorenzana, et al.
Current Biology : CB
|
January 24, 2004
The vertebrate Ndc80 complex contains Spc24 and Spc25 homologs, which are required to establish and maintain kinetochore-microtubule attachment
Mark L McCleland, Marko J Kallio, Gregory A Barrett-Wilt, et al.
The Journal of Pathology
|
August 4, 2015
Cdk8 deletion in the Apc(Min) murine tumour model represses EZH2 activity and accelerates tumourigenesis
Mark L McCleland, Tim M Soukup, Scot D Liu, et al.
Blood
|
April 4, 2002
Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy
Jane D Mount, Roland W Herzog, D Michael Tillson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 11, 2012
Lactate dehydrogenase B is required for the growth of KRAS-dependent lung adenocarcinomas
Mark L McCleland, Adam S Adler, Laura Deming, et al.
ACS Medicinal Chemistry Letters
|
March 18, 2016
Development of a Potent, Specific CDK8 Kinase Inhibitor Which Phenocopies CDK8/19 Knockout Cells
Michael F T Koehler, Philippe Bergeron, Elizabeth M Blackwood, et al.
Cancer Research
|
November 10, 2012
An integrated genomic screen identifies LDHB as an essential gene for triple-negative breast cancer
Mark L McCleland, Adam S Adler, Yonglei Shang, et al.
ACS Medicinal Chemistry Letters
|
June 22, 2016
Design and Development of a Series of Potent and Selective Type II Inhibitors of CDK8
Philippe Bergeron, Michael F T Koehler, Elizabeth M Blackwood, et al.
Genes & Development
|
May 3, 2014
An integrative analysis of colon cancer identifies an essential function for PRPF6 in tumor growth
Adam S Adler, Mark L McCleland, Sharon Yee, et al.
Page
of 2